HWANG LARN enters ONCOTELIC THERAPEUTICS, INC. with 4.10M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/2/2019ACC: 0001683168-19-001345
4.10M
Baseline shares
100% direct
4.10M
Direct ownership
1 position
19.35M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned4.10M
Total
4.10M direct4.10M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.10M | Direct |
| Total | 4.10M | 4.10M direct |
Derivative Holdings1
Series A Convertible Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
19.35M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
19.35M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Direct | Common Stock | — | — | 19.35M | N/A | |
| Total | 19.35M | 0.00 | ||||